RobertMichaelAnthenelliMD

Addiction

Professor, Department of Psychiatry, University of California, San Diego, School of Medicine; Director, Pacific Treatment and Research Center; La Jolla, CA

Join to view full profile

Dr. Anthenelli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Anthenelli's full profile

Already have an account?

Office
200 W Arbor Dr
San Diego, CA 92103
Phone+1 800-926-8273

Fax+1 888-539-8781

Summary

Dr. Robert Anthenelli is a Professor of Psychiatry at the University of California, San Diego, School of Medicine where he directs the Pacific Treatment and Research Center. He received his medical degree from the Johns Hopkins University School of Medicine and did his residency and fellowship at UC San Diego and VA San Diego Healthcare System. He specializes in addiction psychiatry.

Education & Training

University of California (San Diego) Medical CenterResidency, Psychiatry, 1987 - 1990
Johns Hopkins University School of MedicineClass of 1986

Certifications & Licensure

CA State Medical License 1988 - 2025
OH State Medical License 1986 - 2021
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Alcohol and Gender Effects on Stress Circuit Function Start of enrollment: 2003 Sep 01
Completed
Not Applicable
Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI) Start of enrollment: 2005 Feb 01
Completed
Phase 2
Topiramate to Aid Smoking Cessation in Alcohol Dependent Men Start of enrollment: 2009 Jan 01
Completed
Phase 2
New Treatment for Alcohol and Nicotine Dependence Start of enrollment: 2011 Sep 01
Active, not recruiting
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

Effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Treating Smoking Among Persons With Current or Past Major Depressive Disorder: Secondary Analysis of ...
George Kypriotakis, Paul M Cinciripini, Charles E Green, David Lawrence, Robert M Anthenelli
The American Journal of Psychiatry. 2024-12-11
Do tobacco regulatory and economic factors influence smoking cessation outcomes? A post-hoc analysis of the multinational EAGLES randomised controlled trial.
Belinda Daniel, David E Lawrence, Benjamin S McKenna, Phillip Saccone, Thomas McRae
BMJ Open. 2024-09-20
Sex differences in alcohol's effects on fronto-amygdalar functional connectivity during processing of emotional stimuli.
Benjamin S McKenna, Robert M Anthenelli, Marc A Schuckit
Alcohol, Clinical & Experimental Research. 2024-04-01

Journal Articles

Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers
Robert M Anthenelli, Neal L Benowitz, JAMA

Press Mentions

$11.4 Million NIH Grant Advances Drug to Treat Nicotine AddictionSeptember 16th, 2020
Zafiris J. Daskalakis, MD, PhD, Named Chair of the Department of PsychiatryJuly 30th, 2020
Study Identifies Predictors of Psychiatric Events During Drug-Assisted Smoking CessationFebruary 27th, 2019
Join now to see all

Grant Support

New Pharmacotherapy For Alcohol And Co-Morbid DisordersNational Institute On Alcohol Abuse And Alcoholism2010–2011
Predicting Alcoholics'Treatment Responses To An SSRINational Institute On Alcohol Abuse And Alcoholism2004–2008
Alcohol And Gender Effects On Stress Circuit FunctionNational Institute On Alcohol Abuse And Alcoholism2003–2008
Scientific Review And Evaluation AwardNational Institute On Alcohol Abuse And Alcoholism2004
Clinically Relevant Markers Of Alcoholic SubgroupsNational Institute On Alcohol Abuse And Alcoholism1996–1997
Clinically Relevant Markers Of Alcoholic SubgroupsNational Institute On Alcohol Abuse And Alcoholism1993–1996